Beta
Baloxavir
medication Under reviewAn antiviral medication used to treat and prevent influenza by inhibiting viral replication.
Research summary
Clinical trials in healthy human subjects with confirmed influenza demonstrate that baloxavir marboxil effectively reduces symptom duration, viral load, and transmission risk compared to placebo, with similar efficacy to oseltamivir but with a more convenient single-dose regimen. Evidence supports its safety profile, showing low rates of adverse events comparable to standard treatments, establishing it as a valuable option for early influenza management in healthy adults.
Reported Benefits
No reports yet
Be the first to report this effect and help the community.
Add Baloxavir to your stack to report effects
Study to Assess the Efficacy of Baloxavir Marboxil Versus Placebo to Reduce Onward Transmission of Influenza A or B in Households
Not specified
Study on the clinical efficacy and safety of baloxavir marboxil tablets in the treatment of influenza A.
Not specified in excerpt
Single-dose baloxavir linked to reduced influenza transmission
Not specified
A Study of S-033188 (Baloxavir Marboxil) in Otherwise Healthy Participants With Influenza-Like Illness
Not specified
Phase III CAPSTONE-1 study of baloxavir marboxil in otherwise healthy people
Roche
No reports yet
Be the first to report this effect and help the community.
Add Baloxavir to your stack to report effects
A Study of S-033188 (Baloxavir Marboxil) in Otherwise Healthy Participants With Influenza-Like Illness
Not specified
No reports yet
Be the first to report this effect and help the community.
Add Baloxavir to your stack to report effects
A Study of S-033188 (Baloxavir Marboxil) in Otherwise Healthy Participants With Influenza-Like Illness
Not specified
No side effects tracked yet
No side effects have been reported by studies or users for this habit yet.
Research (5 studies)
Study on the clinical efficacy and safety of baloxavir marboxil tablets in the treatment of influenza A.
Not specified in excerpt
Study to Assess the Efficacy of Baloxavir Marboxil Versus Placebo to Reduce Onward Transmission of Influenza A or B in Households
Not specified
Single-dose baloxavir linked to reduced influenza transmission
Not specified
Phase III CAPSTONE-1 study of baloxavir marboxil in otherwise healthy people
Roche
A Study of S-033188 (Baloxavir Marboxil) in Otherwise Healthy Participants With Influenza-Like Illness
Not specified
Community updates
No updates yet for this supplement.
Be the first to share your experience!